Defence Therapeutics Inc.
DTC
Rank in Stocks
#29780
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Share Price
$0.24953854
Last synced: 2026-10-16
Market Cap
$18.91M
Change (1 day)
-5.56%
Change (1 year)
-53.23%
Country
CA
Trade Defence Therapeutics Inc. (DTC)
Category
Healthcare
Market Capitalization of Defence Therapeutics Inc.(DTC)
Market Cap: $18.91M
As of October 2026 Defence Therapeutics Inc. has a market cap of $18.91M. This makes Defence Therapeutics Inc. the world's 29780th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Defence Therapeutics Inc. from 2021 to 2026
DTC compared with Top 5 Most Popular stocks
